Alpha 2.0
Login Register
» Articles » PMID: 40088923

Now Where Do We STAND with Crizanlizumab?

Overview
Journal Lancet Haematol
Specialties Hematology
Oncology
Date 2025 Mar 15
PMID 40088923
Authors
Sebastian Mendez-Marti
Swee Lay Thein
Affiliations
Soon will be listed here.